Skip to content

Investigator

Francesca E. Duncan

NORTHWESTERN UNIVERSITY · funded by NIA, NICHD

Companies
1

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$1.5M

Summed across those awards.

First award
Aug 15, 2021

Latest Jun 15, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R56

    Dysregulated ovulatory debris clearance as a driver of ovarian fibroinflammaging

    $400k

    Jun 15, 2026NIANORTHWESTERN UNIVERSITYNIH RePORTER · 11527276 (opens the source filing in a new tab)

  2. R03

    Improving egg quality through an engineered biomimetic follicular microenvironment

    $160k

    Aug 15, 2025NICHDNORTHWESTERN UNIVERSITYNIH RePORTER · 11212398 (opens the source filing in a new tab)

  3. R13

    Upper Midwest Summit for Reproductive Science

    $10k

    Aug 1, 2023NICHDNORTHWESTERN UNIVERSITYNIH RePORTER · 11134710 (opens the source filing in a new tab)

  4. U54

    Biospecimen Core for Procurement of Human Somatic and Reproductive Tissues for Senescent Cell Mapping

    $462k

    Sep 30, 2021NIABUCK INSTITUTE FOR RESEARCH ON AGINGNIH RePORTER · 11176282 (opens the source filing in a new tab)

  5. R01

    Oocyte genomic instability as a driver of the aging ovarian innate immune response

    $466k

    Aug 15, 2021NICHDNORTHWESTERN UNIVERSITYNIH RePORTER · 11097174 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources